Grading criteria for disease severity by pemphigus disease area index-Reference-Cited by-同舟云学术

Grading criteria for disease severity by pemphigus disease area index

Published:2014-10-25 Issue:11 Volume:41 Page:969-973
ISSN:0385-2407
Container-title:The Journal of Dermatology
language:en
Short-container-title:J Dermatol

Author:

Shimizu Tomoko¹,Takebayashi Toru²,Sato Yuji³,Niizeki Hironori⁴⁵,Aoyama Yumi⁶,Kitajima Yasuo⁷,Iwatsuki Keiji⁶,Hashimoto Takashi⁸,Yamagami Jun¹,Werth Victoria P.⁹¹⁰,Amagai Masayuki¹,Tanikawa Akiko¹

Affiliation:

1. Department of Dermatology; Keio University School of Medicine; Tokyo Japan

2. Department of Preventive Medicine and Public Health; Keio University School of Medicine; Tokyo Japan

3. Department of Center for Clinical Research; Keio University School of Medicine; Tokyo Japan

4. Department of Dermatology; National Center for Child Health and Development; Tokyo Japan

5. Nara Medical University School of Medicine; Nara Japan

6. Okayama University Hospital; Okayama Japan

7. Kizawa Memorial Hospital; Gifu Japan

8. Kurume University School of Medicine; Fukuoka Japan

9. Philadelphia V.A. Medical Center; Philadelphia Pennsylvania USA

10. University of Pennsylvania; Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Dermatology,General Medicine

Reference10 articles.

1. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus;Murrell;J Am Acad Dermatol,2008

2. A randomized double-blind trial of intravenous immunoglobulin for pemphigus;Amagai;J Am Acad Dermatol,2009

3. History of the establishment and revision of diagnostic criteria, severity index and therapeutic guidelines for pemphigus in Japan;Ikeda;Arch Dermatol Res,2003

4. Reliability and convergent validity of two outcome instruments for pemphigus;Rosenbach;J Invest Dermatol,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scoring Criteria for Autoimmune Bullous Diseases: Utility, Merits, and Demerits;Indian Dermatology Online Journal;2024-08-19

2. Factors associated with long‐term complete remission in pemphigus patients receiving rituximab therapy;Journal of the European Academy of Dermatology and Venereology;2024-08-16

3. Exploring the role of vitamin D-VDR pathway in pemphigus foliaceous: a novel perspective on disease pathogenesis;Archives of Dermatological Research;2024-07-03

4. Treatment with immunosuppressants did not increase the risk of COVID-19 in pemphigus patients: A single-center survey-based study;International Immunopharmacology;2024-06

5. Immunobullous Diseases;Rook's Textbook of Dermatology;2024-03-19